Yahoo
Shenzhen - Delayed Quote CNY

Jafron Biomedical Co.,Ltd. (300529.SZ)

17.69 +0.29 (+1.67%)
At close: October 30 at 3:04:19 PM GMT+8
View in AlphaSpace Currency in CNY All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
2,066,345.76
2,011,817.98
2,677,320.71
1,922,348.17
2,491,439.43
Cost of Revenue
454,382.06
428,504.85
514,607.93
389,456.31
440,106.21
Gross Profit
1,611,963.70
1,583,313.13
2,162,712.78
1,532,891.86
2,051,333.23
Operating Expense
751,559.80
843,791.27
1,119,090.50
1,009,734.88
1,046,518.53
Operating Income
860,403.90
739,521.85
1,043,622.28
523,156.98
1,004,814.70
Net Non Operating Interest Income Expense
-37,803.07
-39,469.22
-33,223.88
32,673.10
16,748.88
Pretax Income
783,354.66
660,127.10
1,006,964.19
521,020.06
1,016,808
Tax Provision
127,391.58
128,455.92
192,777.81
95,296.91
135,862.90
Net Income Common Stockholders
654,242.28
532,821.31
820,195.43
436,492.21
889,564.38
Basic EPS
0.84
0.69
1.05
0.55
1.12
Diluted EPS
0.84
0.69
1.05
0.55
1.12
Basic Average Shares
778,481.45
772,204.80
781,138.51
793,622.20
794,253.91
Diluted Average Shares
778,481.45
772,204.80
766,537.79
765,775.81
787,225.12
Total Operating Income as Reported
788,916.06
690,786.48
1,045,365.77
543,819.22
1,029,454.82
Total Expenses
1,205,941.86
1,272,296.13
1,633,698.43
1,399,191.19
1,486,624.73
Net Income from Continuing & Discontinued Operation
654,242.28
532,821.31
820,195.43
436,492.21
889,564.38
Normalized Income
724,275.14
581,602.54
826,584.92
447,305.24
892,773.73
Interest Income
17,490.41
14,471.55
30,996.38
87,960.34
53,262.36
Interest Expense
50,917.66
53,511.83
63,713.30
54,333.08
36,044.03
Net Interest Income
-37,803.07
-39,469.22
-33,223.88
32,673.10
16,748.88
EBIT
834,272.31
713,638.92
1,070,677.49
575,353.15
1,052,852.03
EBITDA
834,272.31
836,142.57
1,197,872.78
670,145.78
1,126,846.90
Reconciled Cost of Revenue
454,382.06
428,504.85
514,607.93
389,456.31
440,106.21
Reconciled Depreciation
129,796.70
122,503.65
127,195.29
94,792.63
73,994.87
Net Income from Continuing Operation Net Minority Interest
654,242.28
532,821.31
820,195.43
436,492.21
889,564.38
Total Unusual Items Excluding Goodwill
-83,633.62
-60,567.16
-7,902.35
-13,233.49
-3,704.31
Total Unusual Items
-83,633.62
-60,567.16
-7,902.35
-13,233.49
-3,704.31
Normalized EBITDA
917,905.94
896,709.73
1,205,775.13
683,379.28
1,130,551.21
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-13,600.76
-11,785.93
-1,512.86
-2,420.47
-494.96
12/31/2022 - 8/2/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: